Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

4.3K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.3K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

192
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
192
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

134
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
134

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis.

Radiology. Imaging cancer·2026
Same author

Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis.

International journal of molecular sciences·2026
Same author

The Rise of Deepfake Medical Imaging: Radiologists' Diagnostic Accuracy in Detecting ChatGPT-generated Radiographs.

Radiology·2026
Same author

Superior Diagnostic Yield of 18 F-rhPSMA-7.3 Compared With 18 F-DCFPyL PET/CT for the Detection of Recurrent Prostate Cancer.

Clinical nuclear medicine·2025
Same author

Comparative benchmarking of the DeepSeek large language model on medical tasks and clinical reasoning.

Nature medicine·2025
Same author

Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response.

JCO precision oncology·2025

Related Experiment Video

Updated: Aug 4, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.2K

FDG PET/CT-based Response Assessment in Malignancies.

Ashwin Singh Parihar1, Farrokh Dehdashti1, Richard L Wahl1

  • 1From the Mallinckrodt Institute of Radiology (A.S.P., F.D., R.L.W.) and Siteman Cancer Center (F.D., R.L.W.), Washington University School of Medicine, 4525 Scott Ave, East Building, #3433, St Louis, MO 63110.

Radiographics : a Review Publication of the Radiological Society of North America, Inc
|March 30, 2023
PubMed
Summary

Accurate cancer treatment response assessment is crucial for patient outcomes. 2-[fluorine 18]fluoro-2-deoxy-d-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) offers early, reliable imaging for evaluating treatment effectiveness in various cancers.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.0K

Related Experiment Videos

Last Updated: Aug 4, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.2K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.0K

Area of Science:

  • Oncology
  • Medical Imaging
  • Nuclear Medicine

Background:

  • Objective response assessment is vital for treatment efficacy and patient survival.
  • Early and accurate assessment guides therapy effectiveness, clinical trial design, and response-adapted therapy.
  • 2-[fluorine 18]fluoro-2-deoxy-d-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) provides functional and structural disease information.

Purpose of the Study:

  • To highlight the role of FDG PET/CT in imaging-based tumor response assessment across malignancies.
  • To explain how FDG PET/CT differentiates responders from non-responders, even with residual masses.
  • To discuss the development and revision of FDG PET/CT response assessment criteria for standardization and improved prediction.

Main Methods:

  • Utilizing FDG PET/CT for functional and structural imaging in cancer patients.
  • Applying established and evolving response assessment criteria based on FDG PET/CT findings.
  • Differentiating treatment outcomes in lymphoma and solid malignancies using metabolic changes.

Main Results:

  • FDG PET/CT can distinguish complete responders from non-responders in lymphoma.
  • In solid tumors, metabolic changes on FDG PET/CT precede structural changes.
  • Standardized FDG PET/CT criteria enhance the predictive performance of response assessment.

Conclusions:

  • FDG PET/CT is a valuable tool for early and accurate tumor response assessment in various cancers.
  • The technique aids in differentiating treatment outcomes and guiding clinical decisions.
  • Ongoing refinement of FDG PET/CT criteria is essential for optimizing its predictive capabilities in oncology.